Hyperfractionated radiation therapy plus chemotherapy in locally advanced cervical cancer: Results of two phase I dose-escalation gynecologic oncology group trials

Gynecologic Oncology

Volumn 75, Issue 3, 1999, Pages 349-355

  Calkins, Alison R ^a   Harrison, Charles R ^b   Fowler Jr , Wesley C ^c   Gallion, Holly ^d   Mangan, Charles E ^e   Husseinzadeh, Nader ^f   Alvarez, Ronald D ^g   Mychalczak, Boris ^h   Podczaski, Edward ⁱ  

^a ST JOSEPH HOSPITAL   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA; MISONIDAZOLE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; BRACHYTHERAPY; CLINICAL ARTICLE; DOSE CALCULATION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; NAUSEA; PRIORITY JOURNAL; RADIOSENSITIVITY; UTERINE CERVIX CANCER; VOMITING;

EID: 0032762338     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5609     Document Type: Article

References (26)

1. Hreshchyshyn M, Aron B, Boronow R, Franklin E W III, Shingleton H M, Blessing J A. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys. 5:1979;317-322.
2. Stehman F B, Bundy B N, Thomas G, Keys H M, d'Ablaing Gerrit, Currie J, Mortel R, Creasman W T. Hydroxyurea versus misonidazole with radiation therapy in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol. 11:1993;1523-1528.
3. Byfield J D, Sharp T R, Frankel S S, Tang S G, Callipari F B. Phase I and II trial of 5-day infused 5-fluorouracil and radiation in advanced cancer of the head and neck. J Clin Oncol. 2:1984;406-413.
4. Byfield J E, Barone R, Mendelsohn J, Frankel S, Quinol L, Sharpt T, Seagren S. Infusional 5-fluorouracil and x-ray therapy for non-resectable esophageal cancer. Cancer. 45:1980;703-709.
5. Fu K K. Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer. 55:1985;2123-2130.
6. Malkasian G D, Decker D O, Jorgensen E P. Chemotherapy of cancer of the cervix. Gynecol Oncol. 5:1976;109-120.
7. Bonomi P, Blessing J A, Stehman F B, DiSaia P J, Walton L, Major F. A randomized trial of three cis-platinum dose schedules in squamous cell carcinoma of the uterine cervix. J Clin Oncol. 3:1985;10-79.
8. Stehman F B, Bundy B N, Keys H, Currie J L, Mortel R, Creasman W T. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix: a preliminary report of the Gynecology Oncology Group. Am J Obstet Gynecol. 159:1988;87-94.
9. Whitney C W, Sause W, Bundy B N, Malfetano J H, Hannigan E V, Fowler W C, Clarke-Pearson D, Liao S. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 17:1999;1339-1348.
10. Heaton D, Yordan E, Reddy S, Bonomi P, Lee M S, Lincoln S, Graham J, Dolan T, Miller A, Philips A. Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy. Gynecol Oncol. 38:1990;323-327.
11. Piver M S, Khalil M, Emrich L J. Hydroxyurea plus pelvic irradiation versus placebo plus pelvic irradiation in nonsurgically staged stage IIIB cervical cancer. J Surg Oncol. 42:1988;120-125.
12. Thomas G, Dembo A, Fyles A, Gadalla T, Beale F, Bean H, Pringle J, Rawlings G, Bush R, Black B. Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol. 38:1990;446-451.
13. Twiggs L B, Potish R A, McIntyre S, Adcock L L, Savage J E, Prem K A. Concurrent weekly cisplatinum and radiotherapy in advanced cervical cancer: a preliminary dose escalating toxicity study. Gynecol Oncol. 24:1986;143-148.
14. Perez C A, Kushka R R, Camel H M, Galakatos A E, Hederman M A, Kao M S, Walz B J. Analysis of pelvic tumor control and impact on survival in carcinoma of the uterine cervix treated with radiation therapy alone. Int J Radiat Oncol Biol Phys. 14:1988;613-621.
15. Withers H R, Peters L J, Thames H D, Fletcher G H. Hyper-fractionation. Int J Radiat Oncol Biol Phys. 8:1982;1807-1809.
16. Lanciano R M, Pajak T F, Martz K, Hanks G E. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys. 25:1993;391-397.
17. Pajak T F, Laramore G E, Marcial V A, Fazekas J T, Cooper J, Rubin P, Curra W J Jr, Davis L W. Elapsed treatment days - a critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys. 20:1991;13-20.
18. Buchler, D, A, Petereit, D, G, Sarkaria, J, N, Chappell, R, Hartmann, T, J, Fowler, J, F, Stitt, J, A, Kinsella, T, J, The adverse effect of treatment prolongation in cervical carcinoma, Int J Radiat Oncol Biol Phys, 27(S1): 129, 1993, (abstract 1).
19. Varghese C, Randgad F, Jose C C, Raveendran P, Subhashini J, Ramadas K, Idicula J, Pais A, Roul R K. Hyperfractionation in advanced carcinoma of the uterine cervix: a preliminary report. Int J Radiat Oncol Biol Phys. 23:1992;393-396.
20. Komaki R, Pajak T, Marcial V A, Rotman M, Grigsby P W, Leibel S A, Eifel P J. Twice-daily fractionation of external irradiation with brachytherapy in bulky carcinoma of the cervix: phase I/II study of the Radiation Therapy Oncology Group. Cancer. 73:1994;2619-2625.
21. Phillips R A, Tolmach J. Repair of potentially lethal damage in x-irradiated Hela cells. Radiat Res. 29:1966;413-432.
22. Eisenberger N A, Denefrio J, Silverman M, Lessner H E. Combination chemotherapy, bleomycin and hydroxyurea in the treatment of advanced head and neck cancer. Cancer Treat Rep. 66:1982;1439-1440.
23. Taylor S G, Showel J. Palliative treatment of head and neck squamous cancer with cisplatin and hydroxyurea. Cancer Treat Rep. 68:1984;932-933.
24. Byfield J E, Calabro-Jones P, Klisak I, Kulhanian F. Pharmacologic requirements of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x-rays. Int J Radiat Oncol Biol Phys. 8:1982;1923-1933.
25. Leichman L, Herskovis A, Leichman C G, Lattin P B, Steiger Z, Tapazoglou E, Rosenberg J C, Arbulu A, Asfaw I, Kinzie J. Nonoperative therapy for squamous cell cancer of the esophagus. J Clin Oncol. 5:1987;365-370.
26. Wang C C. Local control for advanced oropharyngeal carcinoma following twice daily radiation therapy. Am J Clin Oncol. 8:1985;512-516.